Reaction
Lipids Abnormal reporting signals
As of the last recalculation, Lipids Abnormal appears in 708 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is EFAVIRENZ (PRR 29.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Efavirenz | 11 | 29.4 | 29.5 |
| Raltegravir | 14 | 25.4 | 25.4 |
| Lamivudine Oral | 20 | 23.9 | 23.9 |
| Lamivudine | 24 | 23.6 | 23.6 |
| Nevirapine | 7 | 23.0 | 23.0 |
| Inclisiran | 6 | 22.2 | 22.2 |
| Abacavir Sulfate | 7 | 21.3 | 21.3 |
| Darunavir | 10 | 19.7 | 19.7 |
| Pitavastatin Calcium | 6 | 17.4 | 17.4 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 13.7 | 13.7 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 7.8 | 7.8 |
| Isotretinoin | 12 | 7.2 | 7.2 |
| Alirocumab | 6 | 7.1 | 7.1 |
| Evolocumab | 34 | 6.4 | 6.4 |